Loading organizations...
Loading organizations...
Biotech company developing fusion proteins for neurodegenerative diseases.
Illimis Therapeutics has raised $41.8M across 1 funding round.
Illimis Therapeutics has raised $41.8M in total across 1 funding round.
Illimis Therapeutics has raised $41.8M in total across 1 funding round.
Illimis Therapeutics's investors include Yohan Kim, AJU IB Investment, A Ventures, Company K Partners, Daily Partners, GS Ventures, Hana Ventures, IMM Investment, Industrial Bank of Korea, Korea Development Bank, LB Investment, Maple Investment Partners.
Illimis Therapeutics has raised $41.8M across 1 funding round. Most recently, it raised $41.8M Series B in July 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 14, 2025 | $41.8M Series B | Yohan Kim | AJU IB Investment, A Ventures, Company K Partners, Daily Partners, GS Ventures, Hana Ventures, IMM Investment, Industrial Bank of Korea, Korea Development Bank, LB Investment, Maple Investment Partners, QUAD Investment Management, Schmidt, Shinhan Venture Investment, S&S Investment, TS Investment, Jiwoong Chun |